Literature DB >> 21750170

Polymorphisms in nucleotide excision repair genes and endometrial cancer risk.

Jennifer A Doherty1, Noel S Weiss, Sherianne Fish, Wenhong Fan, Melissa M Loomis, Lori C Sakoda, Mary Anne Rossing, Lue Ping Zhao, Chu Chen.   

Abstract

BACKGROUND: Exposure to estrogens increases the risk of endometrial cancer. Certain estrogen metabolites can form bulky DNA adducts, which are removed via nucleotide excision repair (NER), and the ability to carry out this repair might be related to endometrial cancer risk.
METHODS: We examined 64 tag and functional single-nucleotide polymorphisms (SNPs) in the NER genes ERCC1, ERCC2 (XPD), ERCC3 (XPB), ERCC4 (XPF), ERCC5 (XPG), LIG1, XPA, and XPC in a population-based case-control study in Washington state, with 783 endometrial cancer cases and 795 controls.
RESULTS: The presence of ERCC5 rs4150386 C, LIG1 rs3730865 C, XPA rs2808667 T, or XPC rs3731127 T alleles was associated with risk of endometrial cancer, with respective age-, county-, and reference year-adjusted per-allele ORs and 95% CIs of 0.68 (0.53-0.87, P = 0.002), 1.46 (1.02-2.10, P = 0.04), 0.71 (0.52-0.97, P = 0.03), and 1.57 (1.13-2.17, P = 0.007), respectively.
CONCLUSIONS: Certain ERCC5, LIG1, XPA, and XPC genotypes might influence endometrial cancer risk. IMPACT: Because of multiple redundancies in DNA repair pathways (and therefore a low prior probability) and the large number of associations examined, false-positive findings are likely. Further characterization of the relation between variation in NER genes and endometrial cancer risk is warranted.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21750170      PMCID: PMC3169742          DOI: 10.1158/1055-9965.EPI-11-0119

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  25 in total

1.  A method for the assessment of disease associations with single-nucleotide polymorphism haplotypes and environmental variables in case-control studies.

Authors:  Lue Ping Zhao; Shuying Sue Li; Najma Khalid
Journal:  Am J Hum Genet       Date:  2003-04-16       Impact factor: 11.025

2.  Estimating haplotype frequencies and standard errors for multiple single nucleotide polymorphisms.

Authors:  Shuying Sue Li; Najma Khalid; Christopher Carlson; Lue Ping Zhao
Journal:  Biostatistics       Date:  2003-10       Impact factor: 5.899

Review 3.  Molecular mechanisms of estrogen carcinogenesis.

Authors:  J D Yager; J G Liehr
Journal:  Annu Rev Pharmacol Toxicol       Date:  1996       Impact factor: 13.820

Review 4.  Steroid hormones and endometrial cancer.

Authors:  P K Siiteri
Journal:  Cancer Res       Date:  1978-11       Impact factor: 12.701

5.  Genetic factors in catechol estrogen metabolism in relation to the risk of endometrial cancer.

Authors:  Jennifer A Doherty; Noel S Weiss; Robert J Freeman; Douglas A Dightman; Perry J Thornton; John R Houck; Lynda F Voigt; Mary Anne Rossing; Stephen M Schwartz; Chu Chen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-02       Impact factor: 4.254

Review 6.  Functional role of estrogen metabolism in target cells: review and perspectives.

Authors:  B T Zhu; A H Conney
Journal:  Carcinogenesis       Date:  1998-01       Impact factor: 4.944

7.  Nucleotide excision repair as a marker for susceptibility to tobacco-related cancers: a review of molecular epidemiological studies.

Authors:  Ana S Neumann; Erich M Sturgis; Qingyi Wei
Journal:  Mol Carcinog       Date:  2005-02       Impact factor: 4.784

Review 8.  Estrogen, DNA damage and mutations.

Authors:  D Roy; J G Liehr
Journal:  Mutat Res       Date:  1999-03-08       Impact factor: 2.433

Review 9.  Environmental and chemical carcinogenesis.

Authors:  Gerald N Wogan; Stephen S Hecht; James S Felton; Allan H Conney; Lawrence A Loeb
Journal:  Semin Cancer Biol       Date:  2004-12       Impact factor: 15.707

10.  The dose-effect relationship between 'unopposed' oestrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk.

Authors:  T J Key; M C Pike
Journal:  Br J Cancer       Date:  1988-02       Impact factor: 7.640

View more
  22 in total

1.  Predictive impact of genetic polymorphisms in DNA repair genes on susceptibility and therapeutic outcomes to colorectal cancer patients.

Authors:  Kang Sun; Aixia Gong; Pin Liang
Journal:  Tumour Biol       Date:  2014-10-30

2.  Breastfeeding and Endometrial Cancer Risk: An Analysis From the Epidemiology of Endometrial Cancer Consortium.

Authors:  Susan J Jordan; Renhua Na; Sharon E Johnatty; Lauren A Wise; Hans Olov Adami; Louise A Brinton; Chu Chen; Linda S Cook; Luigino Dal Maso; Immaculata De Vivo; Jo L Freudenheim; Christine M Friedenreich; Carlo La Vecchia; Susan E McCann; Kirsten B Moysich; Lingeng Lu; Sara H Olson; Julie R Palmer; Stacey Petruzella; Malcolm C Pike; Timothy R Rebbeck; Fulvio Ricceri; Harvey A Risch; Carlotta Sacerdote; Veronica Wendy Setiawan; Todd R Sponholtz; Xiao Ou Shu; Amanda B Spurdle; Elisabete Weiderpass; Nicolas Wentzensen; Hannah P Yang; Herbert Yu; Penelope M Webb
Journal:  Obstet Gynecol       Date:  2017-06       Impact factor: 7.661

Review 3.  Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer.

Authors:  J Julie Kim; Takeshi Kurita; Serdar E Bulun
Journal:  Endocr Rev       Date:  2013-01-09       Impact factor: 19.871

Review 4.  Genetics of endometrial cancer.

Authors:  Ayelet Shai; Yakir Segev; Steven A Narod
Journal:  Fam Cancer       Date:  2014-09       Impact factor: 2.375

5.  The R156R ERCC2 polymorphism as a risk factor of endometrial cancer.

Authors:  Magdalena M Michalska; Dariusz Samulak; Filip Jabłoński; Hanna Romanowicz; Beata Smolarz
Journal:  Tumour Biol       Date:  2015-09-09

Review 6.  Association between XPF polymorphisms and cancer risk: a meta-analysis.

Authors:  Ting-Yan Shi; Jing He; Li-Xin Qiu; Mei-Ling Zhu; Meng-Yun Wang; Xiao-Yan Zhou; Jiali Han; Hongpin Yu; Rong-Yu Zang; Qingyi Wei
Journal:  PLoS One       Date:  2012-07-02       Impact factor: 3.240

7.  Association between the ERCC5 Asp1104His polymorphism and cancer risk: a meta-analysis.

Authors:  Mei-Ling Zhu; Mengyun Wang; Zhi-Gang Cao; Jing He; Ting-Yan Shi; Kai-Qin Xia; Li-Xin Qiu; Qing-Yi Wei
Journal:  PLoS One       Date:  2012-07-18       Impact factor: 3.240

8.  Association between the XPG Asp1104His and XPF Arg415Gln polymorphisms and risk of cancer: a meta-analysis.

Authors:  Xiao-Feng He; Li-Rong Liu; Wu Wei; Yi Liu; Jiao Su; Su-Lan Wang; Xu-Liang Shen; Xian-Bin Yang
Journal:  PLoS One       Date:  2014-05-06       Impact factor: 3.240

9.  Polymorphisms in the ERCC5 gene and risk of esophageal squamous cell carcinoma (ESCC) in Eastern Chinese populations.

Authors:  Mei-Ling Zhu; Ting-Yan Shi; Hai-Chuan Hu; Jing He; Mengyun Wang; Li Jin; Ya-Jun Yang; Jiu-Cun Wang; Meng-Hong Sun; Huan Chen; Kuai-Le Zhao; Zhen Zhang; Hai-Quan Chen; Jia-Qing Xiang; Qing-Yi Wei
Journal:  PLoS One       Date:  2012-07-26       Impact factor: 3.240

10.  Cross-cancer pleiotropic analysis of endometrial cancer: PAGE and E2C2 consortia.

Authors:  Veronica Wendy Setiawan; Fredrick Schumacher; Jennifer Prescott; Jeffrey Haessler; Jennifer Malinowski; Nicolas Wentzensen; Hannah Yang; Stephen Chanock; Louise Brinton; Patricia Hartge; Jolanta Lissowska; S Lani Park; Iona Cheng; William S Bush; Dana C Crawford; Giske Ursin; Pamela Horn-Ross; Leslie Bernstein; Lingeng Lu; Harvey Risch; Herbert Yu; Lori C Sakoda; Jennifer Doherty; Chu Chen; Rebecca Jackson; Shagufta Yasmeen; Michele Cote; Jonathan M Kocarnik; Ulrike Peters; Peter Kraft; Immaculata De Vivo; Christopher A Haiman; Charles Kooperberg; Loic Le Marchand
Journal:  Carcinogenesis       Date:  2014-05-15       Impact factor: 4.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.